Efficacy and Safety of Intraosseous Antibiotic Prophylaxis in Total Hip Replacement
Part of paid clinical trials in Somerset, New Jersey.
- Sponsor
- Rutgers, The State University of New Jersey
- Study ID
- NCT07549542
- Phase
- PHASE4
- Status
- Enrolling By Invitation
Conditions
- Antibiotic Prophylaxis Surgery
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- CeFAZolin 1000 MG — DRUG1 gram of ancef will be administered intra-osseously into the patient's operative side greater trochanter
- Saline (0.9%, sterile, for infusion) — DRUGnormal saline
Study Details
The goal of this clinical trial is to learn if intraosseous antibiotic (cefazolin) administration can improve antibiotic levels in adults undergoing primary total hip replacement. The main question it aims to answer is: • Does intraosseous cefazolin increase antibiotic concentrations in blood and tissue compared with standard intravenous cefazolin alone? Researchers will compare patients receiving intraosseous cefazolin plus standard intravenous cefazolin to those receiving placebo injection plus standard intravenous cefazolin to see if local antibiotic delivery improves outcomes. Participants will: * Receive standard intravenous cefazolin before surgery and either intraosseous cefazolin or placebo * Provide blood samples before and after antibiotic administration * Have small tissue samples collected during surgery * Complete routine postoperative follow-up and outcome assessment for 90 days
Key Dates
- Start date
- Oct 20, 2025
- Status verified
- Apr 2026
- Primary completion
- Oct 31, 2026
- Completion
- Nov 30, 2026
Study Design
- Enrollment
- 25 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: Intraosseous Ancef50cc mixture of sterile injectable normal saline and one gram of ancef will be administered intra-osseously into the patient's operative side greater trochanter prior to incision
- Placebo Comparator: Intraosseous Saline50cc sterile injectable normal saline will be administered intra-osseously into the patient's operative side greater trochanter prior to incision
Primary Outcome Measure
Cefazolin Concentration [ Time Frame: From administration of intra-osseous ancef to 4 hours post-operatively ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Robert Wood Johnson University Hospital Somerset | Somerset | New Jersey | 08876 | - |